Rheumatologist Humeira Badsha, MD, describes caring for rheumatology patients in the United Arab Emirates, launching the Emirates Arthritis Foundation
7 Things Ophthalmologists Want Rheumatologists to Know
Careful collaboration is key to treating patients with rheumatic or inflammatory diseases that affect the eyes
Rheuminations: Ankylosing Spondylitis Sometimes Defies Detection
How method of diagnosing, treating this inflammatory back disease characterized by stiffness and the presence of HLA-B27 gene has evolved
Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis
New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation
Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium
Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA
Approval Expected for Apremilast
New drug shows promise in treating psoriatic arthritis, ankylosing spondylitis & psoriasis
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Paleopathology Uses Patients from the Past to Investigate Today’s Diseases
Evidence of disease in prehistoric skeletons can provide clues to early characteristics of rheumatoid arthritis, calcium pyrophosphate deposition disease, and other joint disorders
Does Anti-Tumor Necrosis Factor-Alpha Increase Cardiovascular Burden?
Long-term use of TNFα inhibitors in patients with rheumatoid arthritis and ankylosing spondylitis is associated with both gains in fat mass and a shift in fat mass to the visceral region. (posted Jan. 14)
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 19
- Next Page »